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Abstract
Accelerated leukocyte telomere shortening has been previously associated to self-perceived stress and psychiatric disorders,
including schizophrenia and mood disorders. We set out to investigate whether telomere length is affected in patients with
anxiety disorders in which stress is a known risk factor. We also studied the effects of childhood and recent psychological
distress on telomere length. We utilized samples from the nationally representative population-based Health 2000 Survey
that was carried out between 2000–2001 in Finland to assess major public health problems and their determinants. We
measured the relative telomere length of the peripheral blood cells by quantitative real-time PCR from 321 individuals with
DSM-IV anxiety disorder or subthreshold diagnosis and 653 matched controls aged 30–87 years, who all had undergone the
Composite International Diagnostic Interview. While telomere length did not differ significantly between cases and controls
in the entire cohort, the older half of the anxiety disorder patients (48–87 years) exhibited significantly shorter telomeres
than healthy controls of the same age (P=0.013). Interestingly, shorter telomere length was also associated with a greater
number of reported childhood adverse life events, among both the anxiety disorder cases and controls (P=0.005).
Childhood chronic or serious illness was the most significantly associated single event affecting telomere length at the adult
age (P=0.004). Self-reported current psychological distress did not affect telomere length. Our results suggest that
childhood stress might lead to accelerated telomere shortening seen at the adult age. This finding has potentially important
implications supporting the view that childhood adversities might have a considerable impact on well being later in life.
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Introduction
Telomeres consist of DNA repeats and associated proteins
located at the ends of chromosomes. In highly proliferating cells,
such as the germ and stem cells, telomere length is maintained by
the telomerase enzyme, whereas in somatic cells, the activity of
telomerase is low, leading to progressive telomere shortening with
age, providing a marker for cellular aging [1,2]. Leukocyte
telomere length is a complex trait which is regulated by genetic
[3–6] and environmental factors, such as smoking [7], and it has
been associated with many disease phenotypes, such as cardio-
vascular diseases and diabetes [8–10].
An interest to telomere length in psychiatric phenotypes was
awoken when shortened telomere length was associated to self-
perceived stress [11,12], and stress related to caregiving to
Alzheimer’s disease patients [13]. In addition to stress at the adult
age, childhood stress might affect telomere length later in life since
childhood maltreatment was recently associated with telomere
shortening in 31 psychiatrically healthy adults [14]. The
hypothesis that stress affects telomere length is further supported
by animal experiments, as exposing the offspring of wild-caught
mice to stressful conditions led to telomere attrition [15].
Furthermore, negative expectations for the future seem to increase
telomere attrition as pessimism was correlated with leukocyte
telomere length and elevated interleukin-6 levels in a recent study
[16]. Moreover, decreased perceived mental health was associated
with shorter leukocyte telomere length in patients with chronic
heart failure [17]. Regarding psychiatric disorders, shortened
telomere length has been observed in mood disorders [18] and
schizophrenia [19,20] suggesting a putative mechanism explaining
why many psychiatric disorders lead to increased susceptibility to
somatic illness [11].
Anxiety disorders are complex diseases with both genetic and
environmental susceptibility factors. Despite the identification of
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stressful life events and adverse childhood experiences [22–26], the
specific disease mechanisms remain largely unknown. We
hypothesized that accelerated telomere shortening might be
involved in the etiology of anxiety disorders, and set out to test
this hypothesis in anxiety disorder patients and matched controls,
spanning 57 years of age and drawn from a randomly selected
population-based Health 2000 cohort (www.terveys2000.fi). We
additionally hypothesized that advanced age might be needed in
order for stress to have had an effect on telomere shortening and
therefore, we divided the sample by the median age (48 years), and
analyzed these two age groups also separately. In addition, we
investigated the effect of childhood adverse events and recent
psychological distress on telomere length within the same sample.
These both have been reported to associate with current DSM-IV
mental disorders in previous studies of the Health 2000 project
[27,28]. Our results show that there was no difference in the
telomere length between the anxiety disorder patients and controls
in the entire cohort, although older anxiety disorder patients may
have accelerated telomere shortening. Recent psychological
distress did not have an effect on the telomere length, but the
number of childhood adverse life events correlated significantly
with shorter telomere length both in cases and controls.
Results
Telomere length in anxiety disorders
Anxiety disorder cases and two matched controls per case were
identified from the Health 2000 epidemiological cohort, which is a
randomly selected sample of the Finnish population. We measured
the relative telomere length from peripheral blood leucocytes of
the participants using a qPCR-based method [29], in which the
signal value from a qPCR reaction with telomere sequence specific
primers was divided by the signal value from a qPCR reaction
with beta-hemoglobin gene specific primers (single copy control
gene). After quality control, our study sample consisted of 939
individuals between 30 and 87 years of age (Table 1). Figure 1
shows the telomere length as a function of age for anxiety disorder
cases and controls. As expected, age was significantly associated
with telomere length (P=4610
216) in a linear regression analysis,
as telomeres shorten during aging. There was no significant
difference in telomere length between sexes (P=0.154) or between
cases and controls (Table 2).
We then analyzed the two age groups separately. There was no
significant difference in the telomere length between cases and
controls in the younger age group (30–47 years of age). However,
in the older age group (48–87 years of age), the telomere length
was significantly shorter in anxiety disorder cases compared to
controls (b=20.240, se=0.096, P=0.013).
Current stress and telomere length
We examined the role of current psychological distress, as
measured by the 12 questions of the General Health Question-
naire (GHQ-12), on telomere length. Even though the GHQ-12
sum score correlated significantly with the presence of a DSM-IV
anxiety disorder or subthreshold diagnosis (x
2=307.357, df=12,
P,1610
216), it did not have an effect on telomere length (Table 2).
Childhood stress and telomere length
We next investigated the number of childhood adverse life
events as a measure of childhood distress. The number of
childhood adverse life events correlated significantly with the
anxiety disorder diagnosis (x
2=74.087, df=3, P=5.69610
214).
We observed a significant effect of the number of childhood
adversities on the age and sex adjusted telomere length (Table 2,
Figure 2). In order to further explore the specific individual
childhood adversities, we analyzed their effect on telomere length
individually. Parental unemployment (b=20.157, se=0.059,
P=0.008) and own chronic or serious illness (b=20.345,
se=0.088, P=0.0001) showed independent effects, also when
modeled jointly. The effect of the own chronic or serious illness on
telomere length is significant even after correcting for multiple
testing for the number of adversities using the Bonferroni method.
Effect of other telomere length-associated factors
Telomere length might be affected by several biological and
lifestyle factors, including body mass index (BMI) [7,30,31],
smoking [7,32], homocysteine levels [33], cardiovascular disease
risk factors [8,9,34–37], insulin levels or resistance [10,38,39],
diagnosis of diabetes [40,41], sleep duration [16], or physical
inactivity [42]. In addition, factors related to the anxiety disorder
diagnosis, such as medication or other comorbid illnesses, might
have an influence on telomere length. Therefore, we carried out
additional analyses to examine the relationship between the
number of adverse childhood life events, telomere length, and
putative confounders.
Since our cohort is ascertained through anxiety disorder
diagnosis, and 28% of the cases have a comorbid major depressive
disorder and 22% a comorbid alcohol use disorder, we modeled
these factors, the number of childhood adverse life events, and the
telomere length jointly. Only the effect of the number of childhood
adverse life events on telomere length was statistically significant
(b=20.091, se=0.032, P=0.005).
Table 1. The Health 2000 anxiety disorder sample analyzed in this study.
Characteristic Core cases
1 Subthreshold cases
2 Core and subthreshold cases Controls
Number of individuals 282 39 321 653
Age 49.82 (612.74)
3 49.03 (612.97) 49.7 (612.8) 49.8 (612.6)
Women 61.7% 71.8% 62.9% 63.5%
GHQ-12 score
4 5.45 (64.18) 4.92 (64.40) 5.39 (64.21) 1.14 (62.41)
Number of childhood adverse life events 1.92 (61.82) 2.10 (62.00) 1.94 (61.83) 0.97 (61.28)
1Cases meeting DSM-IV anxiety disorder diagnosis.
2Cases meeting DMS-IV subthreshold anxiety disorder diagnosis.
3Mean 6 standard deviation.
4Sum score of the 12-item General Health Questionnaire.
doi:10.1371/journal.pone.0010826.t001
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medication, and studied the effect of benzodiazepine, selective
serotonin reuptake inhibitor, tricyclic antidepressant, other
antidepressant, antipsychotic, and sleep medication on telomere
length together with the number of adverse life events. Again, only
the number of childhood adverse life events had a significant effect
on telomere length (b=20.082, se=0.032, P=0.009).
Risk factors for cardiovascular diseases have been shown to
have an effect on telomere length in several studies. We analyzed
the effect of BMI, systolic and diastolic blood pressure,
homocysteine levels, and triglyceride, high-density lipoprotein
(HDL) and low-density lipoprotein (LDL) levels on telomere length
together with the number of childhood adverse life events. In this
analysis as well, only the number of childhood adverse life events
had a significant effect on telomere length (b=20.079, se=0.031,
P=0.012).
Diabetes and related risk factors have also been associated with
shorter telomere length in many studies. In a model consisting of
the number of childhood adverse life events, diagnosis of diabetes,
BMI, and blood glucose and insulin levels, the number of
childhood adverse life events was the only factor explaining the
shorter telomere length (b=20.085, se=0.031, P=0.006).
In the last model, we examined life style factors, including
physical activity, smoking, and duration of sleep together with
childhood adversities. While the number of childhood adverse life
events had a significant effect on telomere length (b=20.064,
se=0.032, P=0.043), so did smoking (b=20.181, se=0.081,
P=0.018) and duration of sleep (b=20.056, se=0.027,
P=0.037).
Telomere length and sociodemographic factors
In a linear regression model including sociodemographic factors
(age, sex, hospital district, marital status, education, and current
employment status), age was the only significant explaining factor
of the telomere length (data not shown), suggesting that other
sociodemographic factors do not have an effect on telomere length
in this sample.
Discussion
We have observed a correlation between shorter telomere
length at adult age and the reported number of childhood adverse
life events in a subsample of an epidemiological cohort consisting
of anxiety disorder patients and matched controls. Interestingly,
this finding was not dependent on the anxiety disorder status,
although anxiety disorder patients had a larger number of
childhood adversities compared to the controls. The most
significantly associated single adversity was childhood chronic or
severe illness which may affect cellular ageing through yet
unknown direct physiological and indirect psychological mecha-
nisms. The reported childhood adversities may represent a lifelong
course of stress factors, partly traumatic in origin and later
complicated by temporally secondary mental disorders [27]. Our
results can be considered as a partial replication of a recently
Table 2. Telomere length is affected by childhood adverse
life events but not by anxiety disorder diagnosis or recent
psychological stress.
Regression model b
1 se
2 P-value
Anxiety disorder 20.080 0.069 0.224
GHQ-12 score
3 20.002 0.009 0.838
Number of childhood adversities
4 20.090 0.032 0.005
1Difference in standardized telomere length for one unit or category change in
each independent variable.
2Standard error of the mean.
3Sum score of the 12-item General Health Questionnaire.
4Categorized to 0 adversities, 1 adversity, 2 or 3 adversities, and 4 or more
adversities.
Results from three independent regression models are shown in which sex and
age adjusted telomere length was explained by either anxiety disorder status,
GHQ-12 score, or number of childhood adversities.
doi:10.1371/journal.pone.0010826.t002
Figure 2. The number of childhood adverse life events affects
relative telomere length at adult age. Relative telomere length is
adjusted for age and sex. Each bar presents group mean (6 standard
error of the mean).
doi:10.1371/journal.pone.0010826.g002
Figure 1. Telomere length as a function of age. Anxiety disorder
core and subthreshold cases (N=321) are shown with red dots and
controls (N=653) with blue dots, each dot representing one individual.
Regression lines for both groups are shown with the same color coding.
doi:10.1371/journal.pone.0010826.g001
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associated with shorter telomere length at the adult age in 31
individuals with no psychiatric disorders, although different
measures of childhood adversity was used.
Our sample derives from the nationwide Health 2000 Study
which was carried out to assess welfare of Finnish people and
which represents the entire population over 30 years of age [28].
Therefore, we were able to control for a large number of possible
confounders, which is typically not possible in a clinic-based
setting. In addition to childhood adversities, smoking and duration
of sleep affected telomere length. Smoking decreased telomere
length while the duration of sleep correlated positively with it. The
adjustment of telomere length by these two factors decreased the
b-value of the number of adverse life events by about one third,
suggesting that this proportion of the effect may be explained by
these two life-style factors. Smoking has been shown to affect
telomere length in numerous studies e.g. [7,32], but duration of
sleep has not, although some earlier studies did adjust telomere
length by sleep duration [16].
Interestingly, sum score of GHQ, which measures recent
psychological distress, correlated significantly with the anxiety
disorder status, but did not have an effect on telomere length.
Several studies have observed a correlation of shorter telomere
length with current psychological stress [11,12] or more chronic
stress [13], although a negative report exists as well [14]. So far,
our study is the only population-based cohort to investigate the
effect of current psychological stress with telomere length, and the
instruments to measure stress have varied across studies.
Our initial hypothesis was that anxiety disorder patients would
have shorter telomere length compared to controls. However,
telomere length did not differ between anxiety disorder patients
and controls in the entire sample including individuals 30–87 years
of age. In the older half of the patients (48 years or older), we did
observe shorter telomere length in cases compared to controls.
This finding might indicate that prolonged stress related to having
an anxiety disorder might be needed for accelerated telomere
shortening, and this hypothesis should be tested in other anxiety
disorder cohorts.
Although this population-based cohort enabled us to investigate
the relationship of telomere length and anxiety disorders in light of
a multitude of confounding factors, it also has some limitations.
The specimen available to us was DNA samples extracted from
peripheral blood. Because we did not have access to blood
samples, we were limited to only investigate the relative telomere
length, and could not assay telomerase enzyme activity or
oxidative stress markers, factors that have earlier been associated
with perceived stress. Furthermore, the CIDI interview was
conducted to detect present (i.e. past 12-month) anxiety disorder
diagnoses, and therefore we might have missed some patients in
remission. In addition, it would have been interesting to study the
effect of long-term stress on the telomere length, but this was not
possible in our cohort. However, the correlation of the number of
childhood adverse life events and the GHQ sum score was highly
significant (Spearman R=0.279, two-tailed P=5.28610
218),
suggesting a relationship between childhood stress and recent
psychological distress.
Mechanisms that contribute to accelerated telomere shortening
in vivo remain largely unknown. In vitro, oxidative stress has been
shown to shorten telomeres, and antioxidants to reverse the
accelerated telomere shortening induced by increased oxidative
stress [2]. Supporting this hypothesis, Epel et al. [11] observed
higher oxidative stress and shorter telomere length with chronic
psychological stress. In the same sample of 62 healthy women,
telomere length was associated to elevated stress hormone levels,
and telomerase enzyme activity to cardiovascular disease risk
factors [43]. Similarly, increased oxidative stress correlated with
shorter telomere length in a study of insulin resistance and
hypertension [39]. Moreover, it has been suggested that telomere
length might serve as a biomarker of cumulative exposure to
oxidative stress and a prognostic indicator for risk of late-life
diseases [2]. The hypothesis that white blood cell telomere length
is associated to morbidity or mortality has recently been tested, but
the results have been conflicting [44–47]. Interestingly, it has been
shown that maternal diet influences the aortic telomere length
through changes in DNA single stranded breaks, antioxidant
capacity, and oxidative stress in rat pups [48]. Oxidative stress has
been suggested to play a role in the etiology of anxiety disorders,
and support for the involvement of oxidative stress in the
regulation of anxiety-like behavior in rodents has been observed
in several studies [49–53].
Shorter telomere length has been observed in other psychiatric
diseases, including mood disorders [18] and schizophrenia [19],
and in schizophrenia patients with poor treatment response [20].
Importantly, oxidative stress has been shown to be involved in the
etiology of these disorders [54,55]. Another intriguing putative
mechanism involves adult neurogenesis, which has been shown to
be involved in mental health and illness [56]. It was recently
shown that deficient neurogenesis correlates with reductions in
telomere length in adult subependymal zone neural stem cells [57].
Due to the lack of longitudinal studies, it is not known whether
telomere shortening is a cause or a consequence of stress. A recent
work in mice suggests that stress over a period of six months leads
to accelerated telomere shortening in stressed, but not in the
control mice, and even increased telomere length was observed in
some control groups [15]. In humans, telomere lengthening has
been observed in a subset of individuals in two epidemiological
studies in which samples were taken approximately 10 years apart
[58,59]. In both studies the telomere length at the follow-up was
proportional to the telomere length at the baseline, with those
individuals with the shortest telomeres to start with showing no
difference or increase in the telomere length. Interestingly, it has
also been suggested that a comprehensive lifestyle change might
increase telomerase activity, a potential precursor to telomere
length, [60] putatively leading to telomere lengthening over time
as a result of healthier habits and less psychological and
physiological stress, counteracting the influence of a chronic
disease on telomere attrition. Therefore, it might be possible to
affect the telomere length of those individuals with short telomeres
due to childhood physiological or psychological stress, either by
life-style choices or by pharmacological means to be developed.
For this reason further studies on the mechanisms linking stress
and telomere length are needed.
Materials and Methods
Ethics statement
This study was approved by the ethics committee of the
National Public Health Institute and written informed consent was
obtained from all participants.
Study sample
Subjects of this study derive from the population-based
epidemiological Health 2000 cohort collected by the National
Public Health Institute of Finland (since 1 January 2009 the
National Institute for Health and Welfare) during 2000 and 2001.
The cohort was collected to assess the major public health
problems, functioning and their determinants of the adult Finns,
aged 30 years or older [61]. Therefore, we have detailed
Telomeres, Anxiety and Stress
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participants. Altogether 6005 individuals participated in a
structured psychiatric interview (Munich Composite International
Diagnostic Interview, M-CIDI) to diagnose current (past 12
months) mental illness using the DSM-IV criteria [62]. The
anxiety disorders that were diagnosed with the version of M-CIDI
used in this study include panic disorder, generalized anxiety
disorder, social phobia, agoraphobia, and phobia not otherwise
specified. In addition to the individuals meeting the DSM-IV
criteria for these anxiety disorders, the M-CIDI interview enabled
us to identify so called subthreshold cases who do not meet all full
diagnostic criteria, but likely share the same genetic liability and
were included to increase the sample size. The subthreshold cases
fulfil most screen and core symptoms of the specific diagnoses but
the number of additional symptoms may not have added up to the
full DSM-IV criteria. Similar approaches using extended diag-
nostic criteria have been used in both epidemiological and genetic
studies of anxiety disorders [63–65]. The number of cases in each
category was: 108 core panic disorder cases, 73 core and 30
subthreshold generalized anxiety disorder cases, 58 core and 7
subthreshold social phobia cases, 31 core and 15 subthreshold
agoraphobia cases, and 58 core cases of phobia, not otherwise
specified. We then selected two control individuals for each case,
matched by sex, age (+/21 year), and university hospital district
(N=5 in the entire country, each with approximately 1 million
inhabitants). The final sample of individuals with DNA available
included 321 cases and 653 controls. A comorbid other anxiety
disorder was present in 16%, a comorbid major depressive
disorder or dysthymia in 28% and a comorbid alcohol use disorder
in 22% of the cases, as described earlier in more detail [28,66,67].
We also used the available information concerning the current use
of psychiatric medication based on self-report. Current medication
was asked about in the home interview, and in most cases
registered based on prescriptions shown to the interviewer.
In addition to the anxiety-related variables, we analyzed a large
number of other variables available as part of the epidemiological
study [61,68]. Sociodemographic factors included age, sex,
hospital district as described above, marital status (1. married or
living as married, 2. divorced, 3. widow, 4. unmarried), education
(divided into three categories based on information on general
education and on higher and vocational education), and current
employment status (1. full or part-time employed, 2. unemployed
or laid off, 3. retired, 4. other). Mental health related variables
(based on DSM-IV criteria in M-CIDI interview) included major
depressive disorder and/or dysthymia (grouped together as
depressive disorders), as well as diagnosis of alcohol abuse or
alcohol dependence (grouped together as alcohol use disorders).
Since self-perceived stress has been associated to accelerated
telomere shortening, the 12-item GHQ (General Health Ques-
tionnaire) was used to assess whether reported current psycholog-
ical distress has an impact on telomere shortening. Childhood
adverse life events have been shown to be a significant risk factor
for anxiety disorders in this cohort [27]. The questionnaires given
to the subjects during a home interview contained a series of 11
questions about their childhood social environment. The subjects
were instructed to choose ‘‘no’’, ‘‘yes’’, or ‘‘cannot say’’ when
asked the following: ‘‘When you think about your growth years,
i.e., before you were aged 16, …’’
1. Did your family have long-term financial difficulties?
2. Was your father or mother often unemployed although they
wanted to work?
3. Did your father or mother suffer from some serious disease or
disability?
4. Did your father have alcohol problems?
5. Did your mother have alcohol problems?
6. Did your father have any mental health problem, e.g.,
schizophrenia, other psychosis, or depression?
7. Did your mother have any mental health problem, e.g.,
schizophrenia, other psychosis, or depression?
8. Were there any serious conflicts within your family?
9. Did your parents divorce?
10. Were you yourself seriously or chronically ill?
11. Were you bullied at school?
Only ‘‘yes’’ answers were coded positive, and the total number
of reported adversities per subject was recorded from 0 to 11. In
our sample, the highest observed sum score was 9. Cronbach’s
alpha, which measures the relationship between individual
adversity items, was 0.67 in our anxiety disorder subsample of
the Health 2000 cohort (N=974), and 0.60 among all Health
2000 participants (N=8028), suggesting that although there is
some correlation between the responses to the individual items, the
correlation is relatively low and therefore justifies the inspection of
individual questions one by one. We studied the effect of the
number of possibly stressful childhood adversities on telomere
length by categorizing the sum score to four groups: 0 adversities,
1 adversity, 2 or 3 adversities, and 4 or more adversities, in
addition to studying them one at a time.
In addition, we obtained information concerning other factors
that might affect telomere length including BMI, smoking (yes or
no), homocysteine levels, HDL and LDL cholesterol, triglyceride
levels, diastolic and systolic blood pressure, glucose levels, insulin
levels, diagnosis of diabetes, sleeping (hours per night on average),
and physical activity (1. ideal=at least 30 min. leisure time
physical activity at least 4 days a week and at least 30 min. walking
or bicycling to work, 2. adequate=at least 30 min. leisure time
physical activity at least 4 days a week or at least 30 min. walking
or bicycling to work, 3. uncertain, 4. inadequate).
Telomere length measurement
Telomere length was determined from genomic DNA extracted
from peripheral blood by a quantitative real-time PCR-based
method [19,29] with modifications as follows. Relative telomere
length was determined by comparing the value from absolute
quantification of telomere DNA with a single copy reference gene,
ß-hemoglobin (T/S ratio). These two assays were carried out as
separate reactions on separate plates maintaining the sample
positions between the two plates. Amplification signals were
quantified by the standard curve method using a DNA template
series (1.0, 2.0, 5.0, 10, 20, 40, and 60 ng) on every plate. All
randomized DNA samples (15 ng) and standard dilutions were
processed as triplicates onto 384 well plates using a Hydra 96
robot (Robbins Scientific, Sunnyvale, CA, USA), and dried for
24 h at +37uC. Specific reaction mix for telomere reaction
included 270 nM tel1b primer (59-CGGTTT(GTTTGG)5GTT-
39) and 900 nM tel2b primer (59-GGCTTG(CCTTAC)5CCT-39),
150 nM ROX (Invitrogen, Carlsbad, CA, USA), 0.26 SYBR
Green I (Invitrogen, Carlsbad, CA, USA), 5 mM DTT (Sigma-
Aldrich, Saint Louis, MO, USA), 1% DMSO (Sigma-Aldrich,
Saint Louis, MO, USA), 0.2 mM of each dNTP (Fermentas
International, Burlington, Canada), and 1.25 U AmpliTaq Gold
DNA polymerase (Applied Biosystems, Foster City, CA, USA) in a
total volume of 15 ml AmpliTaq Gold Buffer I. Single copy gene
reaction mix included 300 nM Hgb1 primer (59-GCTTCTGA-
CACAACTGTGTTCACTAGC-39) and Hgb2 primer (59-CAC-
CAACTTCATCCACGTTCACC-39) in a total volume of 15 ml
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Finland). The cycling conditions for telomere amplification were:
10 minutes at 95uC followed by 25 cycles at 95uC for 15 s and
54uC for 2 min with signal acquisition. The cycling conditions for
single copy gene amplification were: 95uC for 10 min followed by
35 cycles at 95uC for 15 s, 58uC for 20 s, 72uC for 20 s with signal
acquisition. These procedures were carried out with an ABI
PRISM 7900 HT qPCR machine (Applied Biosystems, Foster
City, CA, USA). Altogether 11 plates were analyzed with telomere
specific primers and 11 plates with ß-hemoglobin specific primers.
We performed rigorous quality control to ensure data quality.
Samples with standard deviation of .0.5 between triplicates were
omitted from the analysis (N=25). We monitored the correlation
coefficient of the standard curves and it was 0.995 on average for
the telomere reaction (range 0.987 to 0.999) and 0.997 on average
for the ß-hemoglobin reaction (range 0.995 to 0.999). The
efficiency of the PCR reaction can be estimated from the slope
of the standard curve, and it was 97.6% on average for the
telomere reaction (range 79.9 to 116.6%) and 100.5% on average
for the ß-hemoglobin reaction (range 92.0 to 107.2%). In addition,
the qPCR plates included a short and a normal telomere length
control DNA samples. The relative normalized signal intensity of
the short telomere control was on average 0.23 (range 0.18 to 0.28)
and 1.17 (range 1.03 to 1.39) on average for the normal telomere
length control. Furthermore, we performed a melting curve
analysis at the end of each reaction to verify specific PCR
amplification.
Statistical analysis
Because the T/S ratios were not normally distributed, we first
transformed these values using the natural logarithm. At this point,
outlier samples (N=10) were removed. We then adjusted for batch
to batch variation, and standardized the T/S ratio values by plate
to the mean of 0 and to the standard deviation of 1.
Statistical analyses were performed using the statistical software
SPSS version 15.0. We confirmed that all assumptions were met
prior to analyses, including examination of normal distribution
graphically using histograms and testing of equal variances with
Levene’s test of the standardized telomere length data in cases and
controls.
Multiple linear regression modeling was used with the
transformed and standardized telomere length as the dependent
variable to assess the influence of anxiety disorders, current stress,
childhood stress, and various covariates on telomere length. Age
and sex were adjusted in regression models. Nominal significance
level was set to p,0.05.
Telomere length and the number of childhood adversities were
visualized using the SPSS version 15.0.
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